MKI67 and benign prostatic hyperplasia: Consistent with the expression of PCNA and cyclin D1, an increased number of Ki-67-positive cells was observed in the prostates of the TP-induced BPH group compared with the NC group; this effect was considerably reduced in both YSTE-treated groups and the finasteride-treated group (Figure 4(b)).